Pravastatin sodium and Gastric infection - a phase IV clinical study of FDA data

Summary:

Gastric infection is reported as a side effect among people who take Pravastatin sodium (pravastatin sodium), especially for people who are female, 60+ old, also take Actemra, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Gastric infection when taking Pravastatin sodium. It is created by eHealthMe based on reports of 23,888 people who have side effects when taking Pravastatin sodium from the FDA, and is updated regularly.

What is Pravastatin sodium?

Pravastatin sodium has active ingredients of pravastatin sodium. It is often used in high blood cholesterol. eHealthMe is studying from 26,520 Pravastatin sodium users. Check the latest studies of Pravastatin sodium.

What is Gastric infection?

Gastric infection (infection of stomach) is found to be associated with 359 drugs and 380 conditions by eHealthMe. Check the latest studies of Gastric infection.

On Jul, 14, 2026

23,888 people reported to have side effects when taking Pravastatin sodium.
Among them, 19 people (0.08%) have Gastric infection.

Could Pravastatin sodium cause Gastric infection?

Among these 19 people:

What is the gender of people who have Gastric infection when taking Pravastatin sodium? *

female: 100 %
male: 0.0 %

What is the age of people who have Gastric infection when taking Pravastatin sodium? *

What are other drugs people take besides Pravastatin sodium? *

What are other side effects people have besides Gastric infection? *

Pain: 15 people, 78.95%
Scratch: 15 people, 78.95%
Muscle Tightness: 15 people, 78.95%
Oxygen Saturation Decreased: 15 people, 78.95%
Gallstones (stone formation by bile component): 15 people, 78.95%
Heart Rate Increased: 15 people, 78.95%
Hepatic Steatosis (fatty liver disease): 15 people, 78.95%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 15 people, 78.95%
Ligament Sprain (ligament stretched): 15 people, 78.95%
Drug Ineffective: 15 people, 78.95%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 15 people, 78.95%
Itching: 12 people, 63.16%
Osteoporosis (bones weak and more likely to break): 2 people, 10.53%
Immunodeficiency Common Variable: 2 people, 10.53%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 10.53%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 10.53%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Pravastatin sodium and have Gastric infection?

- Check whether Gastric infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pravastatin sodium:

Pravastatin sodium (26,520 reports)

Browse all side effects of Pravastatin sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gastric infection:

Gastric infection (359 drugs)

Browse all the conditions that are associated with Gastric infection:

Gastric infection (380 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pravastatin sodium (the active ingredients of Pravastatin sodium) and Pravastatin sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.